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ABSTRACT
The detection of bovine leukemia virus (BLV) pro-
viral DNA is an important tool to address whether an 
animal is infected with BLV. Compared with serological 
assays, real-time PCR accounts for greater sensitivity 
and can serve as a confirmatory test for the clarification 
of inconclusive or discordant serological test results. 
However, the high cost related to real-time PCR assays 
has limited their systematic inclusion in BLV surveil-
lance and eradication programs. The aim of the present 
study was to validate a low-cost quantitative real-time 
PCR. Interestingly, by using SYBR Green detection 
dye, we were able to reduce the cost of a single reaction 
by a factor of 5 compared with most common assays 
based on the use of fluorogenic probes (i.e., TaqMan 
technology). This approach allowed a highly sensitive 
and specific detection and quantification of BLV provi-
ral DNA from purified peripheral blood leukocytes and 
a milk matrix. Due to its simplicity and low cost, our 
in-house BLV SYBR quantitative real-time PCR might 
be used either as a screening or as a confirmatory test 
in BLV control programs.
Key words: bovine leukemia virus, proviral DNA, 
real-time polymerase chain reaction, epidemiology
INTRODUCTION
Bovine leukemia virus (BLV) is a deltaretrovirus 
from the Orthoretrovirinae subfamily and Retroviri-
dae family. The BLV causes a persistent infection in 
cattle, and in most cases this infection is asymptom-
atic (Ghysdael et al., 1984). In one-third of infected 
animals the infection progresses to a state of persistent 
lymphocytosis, and in 1 to 10% of infected cattle it 
develops into lymphosarcoma (Ghysdael et al., 1984). 
Bovine leukemia virus is distributed worldwide with 
the exception of Western Europe and Oceania. This 
virus was first found in Argentina in 1973; since then, 
BLV rapidly spread throughout the region (Ciprian, 
1973; Trono et al., 2001). A recent study highlighted 
that the average within-herd prevalence of BLV in the 
main productive area of Argentina was 80% (Gutiérrez 
et al., 2012). High prevalence of BLV is associated with 
a significant economic impact on the dairy industry 
due to trade restrictions, replacement cost, reduced 
milk production, immunosuppression, and increased 
susceptibility to pneumonia, diarrhea, mastitis, and so 
on (Trainin et al., 1996; Bartlett et al., 2014; Frie and 
Coussens, 2015).
Classic BLV eradication programs rely on the cor-
rect identification and segregation or elimination of 
BLV-infected animals. Serologic assays for the detec-
tion of BLV-specific antibodies in sera and milk have 
been widely used as screening tests due to their high 
sensitivity and ability to test a large number of samples 
at a very low cost. In this regard, the agar gel im-
munodiffusion and ELISA are both cited as prescribed 
tests (OIE, 2012). However, serologic tests might fail to 
detect BLV-specific antibodies in samples from animals 
that have been recently infected with BLV due to the 
low level of BLV-specific antibodies present in these 
particular samples (Eaves et al., 1994). Furthermore, 
the inclusion of highly sensitive screening assays might 
increase the efficiency of a particular eradication 
program, especially for herds with a low within-herd 
prevalence. For that reason, the development and vali-
dation of more sensitive assays for BLV testing in cattle 
are necessary.
Nucleic acid amplification tests, such as PCR, allow 
a rapid and highly sensitive detection of BLV proviral 
DNA, even during recent infection. Compared with se-
rological assays, quantitative real-time PCR (qPCR) 
not only allows the detection of BLV infection but also 
allows the estimation of BLV proviral load, which di-
rectly correlates with the disease stage and the risk of 
disease transmission (Yuan et al., 2015; Juliarena et 
al., 2016). Additionally, qPCR assays can serve as con-
firmatory tests for the clarification of inconclusive and 
discordant serological test results (Rola-Łuszczak et al., 
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2013). Several qPCR assays have been developed for 
BLV proviral DNA detection (Lew et al., 2004; Heene-
mann et al., 2012; Rola-Łuszczak et al., 2013). Previous 
studies comparing pol, gag, and env genes reported that 
pol was the most suitable gene to target for detection 
purposes because it provided the most sensitive assays 
(Rola-Łuszczak et al., 2013). This might be in part due 
to a higher sequence conservation of pol among strains 
from different geographical areas. Importantly, most of 
these assays are based on the use of fluorogenic probes, 
making them very expensive for use as screening tests 
in BLV eradication programs.
The aim of the present study was to validate a low-cost 
qPCR for the detection of BLV proviral DNA. For that 
purpose we used an international panel of BLV proviral 
DNA samples and a set of field samples obtained from 
the main productive area of Argentina. Overall, the 
assay allowed a highly sensitive and specific detection 
of BLV proviral DNA from purified peripheral blood 
leukocytes (PBL) and a milk matrix.
MATERIALS AND METHODS
Reference Samples
Bovine leukemia virus DNA reference samples were 
obtained from 12 serologically positive and 2 serologi-
cally negative cattle from 7 countries (Ukraine, Rus-
sia, Moldova, Croatia, Japan, Argentina, and Poland). 
The number of BLV proviral DNA copies in each of 
these samples was determined by qPCR in 5 labora-
tories worldwide: (1) the Molecular and Cellular Bi-
ology Laboratory of Gemboux, University of Liege, 
Liege, Belgium; (2) the Institute of Virology, Center 
for Infectious Diseases, University of Leipzig, Leipzig, 
Germany; (3) the Department of Veterinary Medicine, 
Iwate University, Iwate, Japan; (4) the National Veteri-
nary Research Institute (NVRI), Pulawy, Poland; and 
(5) the Animal and Plant Health Agency, Weybridge, 
United Kingdom. Three laboratories at the Animal and 
Plant Health Agency, NVRI, and Leipzig University act 
as the World Organization of Animal Health reference 
laboratories for enzootic bovine leukemia. The average 
number of BLV copies in these samples ranged from 
10 to 50,000/µg of total DNA (Table 1). The reference 
panel was kindly provided by Jacek Kuzmak (NVRI, 
Poland).
Field Samples Collection and DNA Extraction
Field samples were obtained from a dairy farm locat-
ed in Rafaela, Santa Fe, Argentina (31°16S, 61°29W). 
This region belongs to the main dairy-producing area 
of the country, with an average within-herd prevalence 
of BLV of 80%. The farm comprised a milking herd (n 
= 330 Holstein cows), 64 dry cows, 94 heifers (>1 yr) 
and 123 calves (<1 yr). The BLV serological status of 
all animals was determined by ELISA at the time that 
the study was initiated. Consistent with other farms lo-
cated in the same region, the individual cow prevalence 
for this particular farm was close to 90%. For this study, 
a total of 67 animals (>1 yr) were randomly selected 
Table 1. Bovine leukemia virus (BLV) quantitative real-time PCR feasibility and reproducibility using a 
reference panel












A (–)  NA4 0 0.0 NA 8 0
B (–) NA 0 0.0 NA 8 0
C (+) 45,000 22.74 0.28 1.23 8 8
D (+) 10,000 23.61 0.09 0.40 8 8
E (+) 8,000 24.25 0.08 0.35 8 8
F (+) 2,000 26.39 0.10 0.37 8 8
G (+) 1,000 28.55 0.19 0.66 8 8
H (+) 500 28.88 0.32 1.10 8 8
I (+) 500 29.00 0.41 1.40 8 8
J (+) 400 29.02 0.14 0.47 8 8
K (+) 400 29.92 0.22 0.72 8 8
L (+) 10 30.71 0.67 2.18 8 8
M (+) 100 31.05 0.44 1.41 8 8
N (+) 50 31.64 0.71 2.25 8 8
1− = negative; + = positive.
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based on their serological status (24 BLV sero-negative 
and 43 BLV sero-positive animals). Sero-conversion 
was investigated in all negative animals 60 d after the 
original screening. The procedures used for animal han-
dling and sampling were approved by the Institutional 
Animal Care and Use Committee of the INTA. The 
guidelines described in the institutional manual were 
followed at all times. Peripheral blood leukocytes were 
isolated from field samples by centrifugation at 1,500 
× g for 25 min, and erythrocytes were hemolysed by 
osmotic shock with H2O and 4.5% NaCl. After 2 washes 
in PBS, the supernatant was discarded and the cell 
pellet was used for extraction of genomic DNA. The 
genomic DNA was extracted using High Pure PCR 
Template Preparation Kit (Roche, Penzberg, Germany) 
according to the manufacturer’s instructions. The DNA 
concentration was calculated using a nanophotometer 
(Nanodrop, Thermo Fisher Scientific, Waltham, MA). 
The DNA samples were stored at −80°C until use.
Cost Analysis of BLV Real-Time qPCR
TaqMan versus SYBR Green (both now from Ther-
mo Fisher Scientific) dye detection system costs were 
compared as part of the cost analysis. In this analysis, 
we considered the prices of reagents and consumables 
included in each of these qPCR reactions. Additionally, 
we focused on those supplies that we have access to in 
Argentina and those that are regularly purchased by 
our laboratory. Costs related to personnel, equipment, 
and facilities were not included in the present analysis. 
The cost associated with the extraction method was 
not considered either.
BLV SYBR Green Real-Time qPCR
The original BLV qPCR protocol described by Rola-
Łuszczak et al. (2013) was adapted to be used with an 
SYBR Green dye detection system. Briefly, each BLV 
SYBR qPCR reaction contained Fast Start Universal 
SYBR Green Master Mix (Roche), 800 nM forward and 
reverse primers (BLV pol 5f: 5′-CCTCAATTCCCTT-
TAAACTA-3′; BLV pol 3r: 5′-GTACCGGGAAGACTG-
GATTA-3′), and 500 ng of DNA template. The reac-
tion was performed on an ABI 7500 machine (Thermo 
Fisher Scientific) with the following cycling conditions: 
2 min at 50°C; 95°C for 10 min; followed by 40 cycles 
of 95°C for 15 s, 55°C for 15 s, and at 60°C for 1 min. 
As standard, the plasmid pBLV1 (kindly provided by 
Jacek Kuzmak, NVRI) containing BLV pol fragment 
was used. Ten-fold dilutions of this standard were made 
from 5 × 106 copies/µL to 5 × 100 copy/µL. A strong 
and a weak positive control as well as a negative control 
and a no-template control were included in each plate.
Validation of BLV SYBR qPCR
Feasibility, Reproducibility, and Analytical 
Sensitivity of BLV SYBR qPCR. To determine 
the feasibility of our in-house BLV SYBR qPCR, we 
analyzed 14 DNA samples from the reference panel 
(12 BLV-positive and 2 BLV-negative samples). These 
samples were tested in duplicate in 4 different runs of 
the assay. The specificity of each positive reaction was 
confirmed by dissociation curve analysis [melting tem-
perature (Tm) pol amplicon = 81.0 ± 1.0°C]. In addition, 
all samples amplified by BLV SYBR qPCR were as-
sayed by electrophoresis in agarose gel to confirm these 
results.
The preliminary reproducibility of the BLV SYBR 
qPCR was determined based on the level of variability 
of the cycle thresholds (Ct) obtained for different rep-
licates of each reference sample. To determine the ana-
lytical sensitivity of the BLV SYBR qPCR, we selected 
the sample with the lowest Ct from the reference panel 
(sample C from Table 1). Based on the information 
provided by the reference laboratory regarding BLV 
copy numbers, 10-fold serial dilutions of this sample 
were performed from 2 × 103 to 2 × 10−1 copies of BLV 
proviral DNA per reaction. These series of dilutions 
were assayed by BLV SYBR qPCR in 8 replicates.
Standard Curve for Quantification of BLV 
Pol Copy Number. A plasmid containing BLV pol 
fragment (pBLV1) was used as standard. The plas-
mid pBLV1 was kindly provided by Jacek Kuzmak at 
NVRI. To build a standard curve, 10-fold serial dilu-
tions of the plasmid pBLV1 were performed from 5 
× 106 to 5 × 100 copies per reaction. Except for the 
dilution 5 × 106, which was tested in 16 replicates, all 
the dilutions were tested in 36 replicates (2 replicates 
per run in 18 runs of the assay). The reproducibility 
of the BLV SYBR qPCR was estimated by analyzing 
the coefficient of variation (CV) for each point of the 
standard curve. The efficiency, coefficient of determina-
tion, and dynamic range of the BLV SYBR qPCR were 
also estimated.
Efficiency of BLV SYBR qPCR Using a Milk 
Matrix. To test the efficiency of the BLV SYBR qPCR 
in a milk matrix, the standard pBLV1 was 10-fold se-
rially diluted in bulk milk from uninfected cows. For 
this purpose we pooled individual milk samples from 
3 BLV sero-negative animals from the same herd. The 
BLV status in these animals was confirmed by testing 
individual plasma and milk samples by BLV qPCR. 
Then, the total DNA from each dilution was purified by 
testing individual blood and milk samples using a High 
Pure PCR Template Preparation Kit (Roche) accord-
ing to the manufacturer’s instructions. Each fraction 
was assayed in 8 replicates from 4 independent runs by 
Journal of Dairy Science Vol. 101 No. 7, 2018
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BLV SYBR qPCR. The analytical sensitivity of BLV 
SYBR qPCR in this milk matrix was also tested.
Diagnostic Performance of BLV SYBR 
qPCR. A total of 67 field samples (described above) 
were tested to evaluate the diagnostic sensitivity and 
specificity of the BLV SYBR qPCR. The BLV status 
in these animals was confirmed by BLV nested PCR 
and the detection of BLV-specific antibodies in plasma 
by ELISA (see description of these assays below). Ad-
ditionally, the analytical specificity of the BLV SYBR 
qPCR was determined through the analysis of several 
cell lines infected with other viruses that frequently 
cause infections in cattle, such as enterovirus, bovine 
herpesvirus, bluetongue virus, and bovine respiratory 
syncytial virus.
BLV Nested PCR
The BLV nested PCR (nPCR) was adapted from 
Kerkhofs et al. (1998). Briefly, the first round of the re-
action contained 5× Colorless GoTaq Buffer (Promega, 
Fitchburg, WI), 0.5 U of Taq Polymerase (Promega), 5 
mM of each deoxynucleotide triphosphate (Promega), 
350 nM of each primer (outer forward: 5′-ctcacttct-
gcttcaccatcc-3′; outer reverse: 5′-ggcaggcatgtagaga-
gtgg-3′), and 100 to 1,000 ng of DNA template in a 
total reaction volume of 25 µL. The first reaction was 
performed with the following cycling conditions: 5 min 
at 95°C; followed by 20 cycles at 95°C for 1 min, 61°C 
for 1 min, and 72°C for 1 min; followed by a last exten-
sion of 72°C for 5 min. The second round of the reaction 
contained 5× Green GoTaq Buffer (Promega), 0.5 U 
of Taq Polymerase (Promega), 5 mM deoxynucleotide 
triphosphates (Promega), 350 nM of each primer (inner 
forward: 5′-tggaaagaactaacgctgacgg-3′; inner reverse: 
5′-ccccaaccaacaacacttgctt-3′), and 1 µL of the product 
from the first round in a total volume of 25 µL. The 
conditions for this second round were 5 min at 95°C; 
followed by 35 cycles at 95°C for 45 s, 65°C for 45 s, 
and 72°C for 1 min; followed by a last extension of 
72°C for 5 min. The presence of BLV proviral DNA was 
evidenced by visualization of a 610-bp fragment corre-
sponding to the pX region of the BLV genome. Positive 
and negative internal controls as well as nontemplate 
controls (for each round of reaction) were included in 
each run of the assay
ELISA for the Detection of Anti-BLV Antibodies
Plasma-specific antibodies against the whole BLV 
viral particle were measured by indirect ELISA as de-
scribed previously (Trono et al., 2001). Briefly, ELISA 
plates were coated with antigen, from fetal lamb kid-
ney cells persistently infected with BLV, purified by 
centrifugation on a sucrose cushion. The samples to 
be tested were added to the plate in duplicate. Based 
on preliminary data, plasma samples were prediluted 
1:40. After incubation and washing, anti-bovine IgG 
peroxidase conjugated was added to each well. The 
presence of secondary antibody was revealed with 3′, 
3′, 5′, 5′;-tetramethylbenzidine and H2O2. Reaction was 
stopped using H2SO4, and the absorbance was read at 
450 nm. Normalized results were obtained as a sample 
to positive ratio. A weak positive control serum was 
used to calculate the ratio. The difference between the 
raw OD obtained for the weak positive control and a 
negative control was set to 100%. All tested samples 
were referred to it. A cut-off level of 25% was established 
in the original work over 339 serum samples using PCR 
and southern blot as confirmatory tests (Trono et al., 
2001). The sensitivity and specificity of the assay were 
of 97.2 and 97.5, respectively. Those samples with reac-
tivity above the cut-off level were considered positive.
RESULTS
Cost Analysis of BLV qPCR
We compared costs of 2 detection systems extensively 
used in qPCR: TaqMan and SYBR Green (Supplemen-
tal Table S1; https:// doi .org/ 10 .3168/ jds .2017 -14253). 
By using the SYBR Green detection dye in our in-
house BLV qPCR, we reduced the cost per reaction 
from US$3.11 (TaqMan detection system) to US$0.71 
(SYBR Green dye).
Feasibility, Reproducibility, and Analytical  
Sensitivity of BLV SYBR qPCR
Our in-house BLV SYBR qPCR detected true posi-
tive (n = 12) and negative (n = 2) samples from an 
international reference panel with a 100% concordance 
(Table 1). When dissociation curves analysis was per-
formed on these samples, we observed that all positive 
samples exhibited the same melting temperature (Tm 
= 81.0 ± 1.0°C). Then, the products from BLV SYBR 
qPCR were assessed by electrophoresis in agarose gel. In 
this opportunity, all positive samples showed a specific 
band of 120 bp, confirming that amplification consisted 
of target sequence (data not shown). In contrast, no 
band was observed when BLV SYBR qPCR-negative 
samples were analyzed by gel electrophoresis.
Furthermore, we analyzed the level of variability of 
Ct among replicates of each reference sample to deter-
mine the preliminary reproducibility of the assay. The 
CV obtained for all 12 BLV-positive samples ranged 
from 0.35 to 2.25%.
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With the aim of testing the analytical sensitivity 
of the BLV SYBR qPCR, we performed 10-fold se-
rial dilutions of reference sample C (Table 1) from 2 
× 103 to 2 × 10−1 copies of BLV proviral DNA per 
reaction. Positive results were obtained in 100% of the 
replicates from 2 × 101 dilution and higher (Table 2). 
At dilution corresponding to 2 × 100 copies 4 out of 8 
(50%) replicates were positive, and at lower dilutions 
(2 × 10−1 copies) all replicates were negative. Thus, the 
sensitivity of the BLV SYBR qPCR was set at 2 copies 
per reaction. Additionally, to compare the analytical 
sensitivity of our BLV SYBR qPCR versus BLV nPCR, 
10-fold serial dilutions of sample C from 2 × 103 to 2 
× 10−1 copies of BLV proviral DNA per reaction were 
assayed by BLV nPCR. By nPCR, only 2 out of 6 repli-
cates (33%) corresponding to the dilution 2 × 100 were 
detected as positive (Table 2).
Standard Curve for the Quantification  
of BLV pol Copy Number
To build a standard curve, 10-fold serial dilutions 
of the plasmid pBLV1 ranging from 5 × 106 to 5 × 
100 copies per reaction were assessed by BLV SYBR 
qPCR. Our BLV qPCR revealed positive results for all 
replicates at a dilution of 5 × 102 copies per reaction 
and higher (Table 3). At a dilution corresponding to 5 
× 101 and 5 × 100 copies, 33 out of 36 (91.7%) and 24 
out of 36 (66.7%) replicates were positive, respectively. 
Additionally, the CV values increased as pBLV1 cop-
ies decreased; however, we observed a maximum vari-
ability (CV = 5.06%) at a dilution of 5 × 101 copies. 
Overall, the efficiency of the qPCR reaction was close 
to 100% (slope = −3.44) and the dynamic range of the 
assay encompassed 6 orders of magnitude with a linear 
relationship (R2 = 0.996) between the Ct values and 
the standard DNA input copies (Figure 1). As noted 
in the following section, using this standard curve and 
within this dynamic range, we can assess BLV proviral 
loads from any sample by extrapolating the Ct values 
to BLV copy numbers per reaction.
Efficiency of BLV SYBR qPCR Using a Milk Matrix
With the aim of testing the efficiency and the 
analytical sensitivity of BLV SYBR qPCR in a milk 
matrix, 10-fold serial dilutions of pBLV1 standard in 
bulk milk from BLV-uninfected cows were assayed. 
Repeated testing of our assay revealed 20 copies of 
pBLV1 in 100% of replicates (8/8; Table 4). At a dilu-
tion corresponding to 2 copies, 5 out of 8 replicates 
were positive. Lower plasmid dilutions representing 0.2 
copies of pBLV1 were consistently negative. Hence, the 
preliminary sensitivity of the BLV SYBR qPCR assay 
using a milk matrix was set at 2 copies of BLV proviral 
DNA. Using a milk matrix, our in-house BLV qPCR 


















2 × 103 25.36 1.29 5.09 8 8 (100)  6 6 (100)
2 × 102 29.00 1.15 3.96 8 8 (100)  6 6 (100)
2 × 101 32.69 1.41 4.30 8 8 (100)  6 6 (100)
2 × 100 34.3 1.87 5.46 8 4 (50)  6 2 (33.3)
2 × 10−1 0 0 NA2 8 0 (0)  6 0 (0)
1Cycle threshold.
2Not applicable.
Table 3. Bovine leukemia virus (BLV) qPCR analytical sensitivity using plasma BLV1 standard










5 × 106 14.85 0.20 1.36 16 16 (100)
5 × 105 17.05 0.46 2.69 36 36 (100)
5 × 104 20.33 0.49 2.41 36 36 (100)
5 × 103 23.77 0.71 3.01 36 36 (100)
5 × 102 27.52 0.83 3.03 36 36 (100)
5 × 101 31.22 1.58 5.06 36 33 (92)
5 × 100 34.10 0.98 2.89 36 24 (67)
1Cycle threshold.
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encompassed 4 orders of magnitude with a high linear 
relationship (R2 = 0.987; data not shown). Moreover, 
low CV values observed at the different concentrations 
tested underscored a good reproducibility of the assay 
under these settings (Table 4).
Diagnostic Performance of BLV SYBR qPCR
A total of 67 field samples were tested by BLV 
SYBR qPCR, BLV nPCR, and ELISA, and results 
were compared among the different assays (Table 5). 
Twenty-three of these samples were negative and 41 
were positive by all 3 techniques. From the remaining 
3 samples, 1 (sample 24) was positive by our in-house 
BLV SYBR qPCR and nPCR but negative by ELISA. 
To determine whether discordant results obtained for 
sample 24 were due to an unspecific PCR reaction or 
an incipient BLV infection with undetectable levels of 
BLV-specific antibody by ELISA, all 24 animals that 
initially tested negative by ELISA (the 23 negative 
by all 3 techniques plus the 1 negative by ELISA and 
positive by both PCR) were retested by ELISA 2 mo 
apart from the original screening time point. The sero-
negative status was confirmed in 23 out of 24 animals. 
In contrast, the animal that was initially negative by 
ELISA but positive by PCR (sample 24) seroconverted 
during that period of time. The second set of discor-
dant samples (samples 25 and 26) were also positive 
Figure 1. Standard curve for the quantification of bovine leukemia virus (BLV) pol copy number by BLV quantitative real-time PCR. Each 
dot represents the mean cycle threshold (Ct) value of each dilution tested. pBLV = plasmid BLV. Error bars represent standard deviation. The 
slope and R2 values are represented in the figure.











2 × 103 25.14 0.2 0.9 8 8 (100)
2 × 102 28.29 0.3 0.9 8 8 (100)
2 × 101 32.33 1.0 3.1 8 8 (100)
2 × 100 34.67 0.8 2.4 8 5 (62)
2 × 10−1 0 0 NA2 8 0 (0)
1Cycle threshold.
2Not applicable.
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by ELISA and BLV SYBR qPCR but negative by BLV 
nPCR. Interestingly, the amount BLV proviral DNA 
in both samples was below the dynamic range of the 
BLV SYBR qPCR (<5 copies per reaction). Addition-
ally, to exclude the amplification of other viruses that 
frequently cause infections in cattle, cell lines infected 
with enterovirus, bovine herpesvirus, bluetongue virus, 
and bovine respiratory syncytial virus were investi-
gated. None of these samples tested positive by BLV 
SYBR qPCR.
DISCUSSION
In the present study we validated a low-cost BLV 
SYBR qPCR that might be included as part of any 
eradication program in high-prevalence regions as well 
as in low- or mid-income countries. For that purpose, 
we modified the original protocol described by Kuz-
mak and colleagues and adapted it to be used with the 
SYBR Green detection system (Rola-Łuszczak et al., 
2013). Interestingly, by using SYBR Green detection 
dye in our in-house BLV qPCR, we were able to reduce 
the cost of a single reaction by a factor of 5 compared 
with most common assays based on TaqMan technol-
ogy. Remarkably, our BLV SYBR qPCR assay allowed 
a highly efficient, reproducible, sensitive, and specific 
detection and quantification of BLV proviral DNA from 
PBL and milk matrix.
Although qPCR assays based on SYBR Green dyes 
are in general less sensitive and specific than TaqMan-
based assays, we showed that our BLV SYBR qPCR 
displayed a high sensitivity. In this regard, our assay 
was able to detect as low as 5 copies per reaction of the 
plasmid pBLV1 (carrying BLV pol sequence) in 67% 
of tested replicates. In addition, based on the analysis 
of serial dilutions of a positive reference sample, the 
analytical sensitivity of our BLV SYBR qPCR as-
say was estimated in 2 BLV proviral DNA copies per 
reaction (detecting 50% of tested replicates). These 
observations are in accordance with previous reports 
by Rola-Łuszczak et al. (2013), in which the authors 
detected 1 copy of pBLV1 in 3 out of 5 replicates us-
ing the same set of primers but TaqMan technology. 
Moreover, the analytical sensitivity of our BLV SYBR 
qPCR was similar to the one obtained by nPCR (2 out 
of 6 positive replicates corresponding to a dilution of 
2 copies per reaction). Interestingly, qPCR has several 
advantages compared with nPCR: (1) a shorter reac-
tion time, (2) full automation, (3) results expressed as 
numbers, (4) no need for post-PCR processing, (5) less 
chance of cross-contamination, (6) collection of data 
in real time during the exponential growth phase, (7) 
an increased dynamic range of detection, and (8) the 
Table 5. Diagnostic sensitivity and specificity of bovine leukemia 






Result Ct1 mean Copies/µg of DNA
1 − − −  NA2 0
2 − − − NA 0
3 − − − NA 0
4 − − − NA 0
5 − − − NA 0
6 − − − NA 0
7 − − − NA 0
8 − − − NA 0
9 − − − NA 0
10 − − − NA 0
11 − − − NA 0
12 − − − NA 0
13 − − − NA 0
14 − − − NA 0
15 − − − NA 0
16 − − − NA 0
17 − − − NA 0
18 − − − NA 0
19 − − − NA 0
20 − − − NA 0
21 − − − NA 0
22 − − − NA 0
23 − − − NA 0
24 − + + 30.07 250
25 + − + 38.07 <5
26 + − + 39.12 <5
27 + + + 22.63 153,036
28 + + + 22.35 186,114
29 + + + 22.70 77,645
30 + + + 33.46 34
31 + + + 25.40 7,803
32 + + + 22.93 41,974
33 + + + 24.14 34,717
34 + + + 24.20 33,609
35 + + + 34.62 <5
36 + + + 23.12 67,130
37 + + + 25.83 11,635
38 + + + 28.97 2,089
39 + + + 30.18 695
40 + + + 23.40 55,991
41 + + + 23.72 53,995
42 + + + 25.05 19,265
43 + + + 23.38 65,456
44 + + + 22.11 132,134
45 + + + 27.70 1,607
46 + + + 26.60 3,070
47 + + + 23.50 95,540
48 + + + 23.20 117,119
49 + + + 22.70 164,288
50 + + + 24.10 70,637
51 + + + 23.40 104,680
52 + + + 23.10 127,212
53 + + + 27.20 10,152
54 + + + 23.30 107,239
55 + + + 23.30 149,791
56 + + + 23.0 136,542
57 + + + 23.60 91,447
58 + + + 25.20 33,250
59 + + + 26.30 17,533
60 + + + 22.0 251,430
61 + + + 23.70 88,845
62 + + + 23.40 102,788
63 + + + 23.05 128,710
64 + + + 23.60 102,443
65 + + + 24.90 63,446
66 + + + 24.60 48,246
67 + + + 22.60 169,246
1Cycle threshold.
2Not applicable.
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possibility to quantitate the number of copies present 
in the tested sample.
Regarding the specificity of the assay, the BLV SYBR 
qPCR was able to discern between true-positive and 
true-negative samples from an international reference 
panel. However, SYBR Green dye can bind to any am-
plified product producing a single amplification plot, 
and those amplification plots usually have the same ap-
pearance whether the amplification consists of target, 
nontarget, or a mixture of both. Considering that, the 
reaction specificity was further confirmed by dissocia-
tion curves analysis and electrophoresis in agarose gel. 
Additionally, no false-positive results were observed 
when several cell lines infected with different viruses 
other than BLV were tested by BLV SYBR qPCR. Al-
together, these results highlight the high specificity of 
our in-house BLV qPCR.
Further, we evaluated the diagnostic specificity and 
sensitivity of the BLV SYBR qPCR using a set of 67 
field samples, and the results were compared with those 
obtained by BLV nPCR and ELISA. A total of 3 dis-
cordant results were observed comparing all assays. The 
first one corresponded to 1 sample that tested negative 
by ELISA but positive by BLV nPCR and qPCR. Inter-
estingly, this animal seroconverted in a later time point 
2 mo apart. In contrast, none of the other sero-negative 
samples seroconverted during the same period of time. 
The combination of low levels of BLV proviral DNA 
and undetectable levels of BLV-specific antibodies in 
that particular sample might be indicative of recent 
BLV infection and could explain the discrepancy be-
tween serologic and molecular results observed for that 
particular animal. The second set of samples with dis-
cordant results was positive by ELISA and BLV SYBR 
qPCR but negative by BLV nPCR. Although both 
samples tested positive by BLV SYBR qPCR, we were 
not able to quantify the number of BLV copies in these 
samples because results fell below the dynamic range of 
the assay (<5 BLV copies per reaction). The discrep-
ancy between both molecular tests could be explained 
by the presence of a very low number of copies of BLV 
proviral DNA in these samples and a higher sensitiv-
ity of BLV SYBR qPCR compared with nPCR. The 
failure of nPCR to detect some sero-positive animals 
with very low amounts of BLV provirus has been previ-
ously described by others (Eaves et al., 1994, Reichel 
et al., 1998). The high sensitivity of our BLV SYBR 
qPCR represents an important feature if the assay is 
intended to be used as screening tool because it would 
allow a higher proportion of BLV-infected animals to be 
detected as positive.
The transmission of BLV from cattle to humans is 
a controversial subject. In this regard, the production 
of medically important human recombinant proteins in 
milk might be a source of human exposure to BLV. 
Additionally, the screening of milk samples might be 
useful for any BLV eradication program due to their 
easy accessibility. For that reason, we analyzed the effi-
cacy of our BLV SYBR qPCR to assess the presence or 
absence of BLV proviral DNA in a milk matrix (Kuck-
leburg et al., 2003; Gillet and Willems, 2016; Buehring 
et al., 2017). It has been demonstrated that a variety of 
inhibitors inherent to clinical and environmental matri-
ces can decrease PCR sensitivity (i.e., proteases, com-
plex polysaccharides, lipids, Ca++ ions). Although the 
nucleic acid purification methods remove most of these 
inhibitors, some can co-elute with the DNA. Moreover, 
purification methods might result in low DNA recovery 
when applied to a complex matrix and further affect 
the sensitivity of the qPCR. In the present study, we 
demonstrated that neither the extraction method nor 
the BLV SYBR qPCR were affected by a milk matrix. 
This is important if the assay is intended to be used as 
screening for milk and milk-derived products.
CONCLUSIONS
Overall, the BLV SYBR qPCR described in this 
study is a sensitive and specific method for the detec-
tion of BLV proviral DNA. Due to its simplicity and 
low cost, it might be used as either a screening test or 
a confirmatory test for the clarification of inconclusive 
serological test results. Additionally, it can be used for 
detecting BLV proviral DNA in milk and milk subprod-
ucts, which are important sources of many transgenic 
proteins used in clinical settings.
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